-+ 0.00%
-+ 0.00%
-+ 0.00%

Stifel Maintains Hold on Globus Medical, Lowers Price Target to $80

Benzinga·07/08/2026 13:18:55
Listen to the news
Stifel analyst Tom Stephan maintains Globus Medical (NYSE:GMED) with a Hold and lowers the price target from $95 to $80.